Dr. Virend Somers
ON THE RECORD · 8 verbatim quotes · every quote source-verified
“This is a very exciting time in treating sleep apnea patients,”
Dr. Virend Somers · said date not stated · reported 2026-10-28
Somers expressed enthusiasm about the emerging treatment options for sleep apnea patients.
“We have the CPAP, we have mandibular devices, we have postural therapy, where you try to avoid sleeping on your back, and now we’ve got drug therapies that can potentially not just reduce your apnea, but also make you sleep better ... and reduce the risk of future cardiovascular events.”
Dr. Virend Somers · said date not stated · reported 2026-10-28
Somers described the range of available and emerging sleep apnea treatments, including CPAP, mandibular devices, postural therapy, and new drug therapies.
“A reduction in these measures would predict whether these patients were at increased cardiovascular risk,”
Dr. Virend Somers · said date not stated · reported 2026-10-28
Somers told Fox News Digital that participants experienced reductions in several cardiovascular risk factors including systolic blood pressure and LDL cholesterol.
“There’s hope on the horizon,”
Dr. Virend Somers · said date not stated · reported 2026-10-28
Somers expressed optimism about emerging drug therapies for sleep apnea following the trial results.
“[The participants] reported much improved sleep beyond just the sleep apnea — what we call sleep-related impairment was significantly reduced,”
Dr. Virend Somers · said date not stated · reported 2026-10-28
Somers said improvements in sleep were largely linked to weight loss from retatrutide.
“OSA is often under-diagnosed and under-treated.”
Dr. Virend Somers · said date not stated · reported 2026-10-28
The quote appears in the section of the article discussing Somers's reaction to the retatrutide trial results.
“In diabetics, blood pressure is a key determinant of future cardiovascular risk, and the fact that we were able to reduce it so significantly was both surprising and exciting.”
Dr. Virend Somers · said date not stated · reported 2026-10-28
Somers commented on the significant blood pressure reduction observed among diabetic participants in the trial.
“magnitude of benefit in patients with type 2 diabetes,”
Dr. Virend Somers · said date not stated · reported 2026-10-28
Somers told Fox News Digital that while the results were expected, he was surprised by the magnitude of benefit in patients with type 2 diabetes.